newsfilter
← Latest News
PR Newswire·

Braxia Scientific Appoints Dr. David Greenberg to Board of Directors

TORONTO, May 31, 2021 /PRNewswire/ - Braxia Scientific Corp. (the "Company"), (CSE:BRAX) (OTC:BRAXF) (FWB: 496), a research driven clinical platform developing and providing innovative ketamine treatments for persons with depression and related disorders